COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABEONA THERAPEUTICS INC | COM NEW | 00289Y206 | 2,452,173 | 869,565 | SH | | DFND | 1 | 869,565 | 0 | 0 |
ACCOLADE INC | NOTE 0.500% 4/0 | 00437EAB8 | 96,642,410 | 122,598,000 | PRN | | DFND | 1 | 122,598,000 | 0 | 0 |
ACUTUS MED INC | COM | 005111109 | 1,999,357 | 2,651,667 | SH | | DFND | 1 | 2,651,667 | 0 | 0 |
ADAPTHEALTH CORP | COMMON STOCK | 00653Q102 | 131,694,781 | 10,594,914 | SH | | DFND | 1 | 10,594,914 | 0 | 0 |
ALECTOR INC | COM | 014442107 | 6,531,638 | 1,055,192 | SH | | DFND | 1 | 1,055,192 | 0 | 0 |
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 16,329,940 | 1,046,791 | SH | | DFND | 1 | 1,046,791 | 0 | 0 |
AMEDISYS INC | COM | 023436108 | 109,087,815 | 1,483,179 | SH | | DFND | 1 | 1,483,179 | 0 | 0 |
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 58,220,330 | 1,984,333 | SH | | DFND | 1 | 1,984,333 | 0 | 0 |
ANAPTYSBIO INC | COM | 032724106 | 13,338,880 | 613,000 | SH | | DFND | 1 | 613,000 | 0 | 0 |
ANNEXON INC | COM | 03589W102 | 2,248,065 | 583,913 | SH | | DFND | 1 | 583,913 | 0 | 0 |
APELLIS PHARMACEUTICALS INC | NOTE 3.500% 9/1 | 03753UAB2 | 95,989,624 | 51,793,000 | PRN | | DFND | 1 | 51,793,000 | 0 | 0 |
ARS PHARMACEUTICALS INC | COM | 82835W108 | 72,117,305 | 11,077,927 | SH | | DFND | 1 | 11,077,927 | 0 | 0 |
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 25,783,200 | 3,581,000 | SH | | DFND | 1 | 3,581,000 | 0 | 0 |
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 23,060,100 | 2,765,000 | SH | | DFND | 1 | 2,765,000 | 0 | 0 |
BLUEBIRD BIO INC | COM | 09609G100 | 6,916,500 | 2,175,000 | SH | | DFND | 1 | 2,175,000 | 0 | 0 |
BROOKDALE SR LIVING INC | COM | 112463104 | 48,397,839 | 16,406,047 | SH | | DFND | 1 | 16,406,047 | 0 | 0 |
BROOKDALE SR LIVING INC | NOTE 2.000%10/1 | 112463AC8 | 104,789,706 | 145,955,000 | PRN | | DFND | 1 | 145,955,000 | 0 | 0 |
BUTTERFLY NETWORK INC | *W EXP 02/12/202 | 124155110 | 195,140 | 733,333 | SH | | DFND | 1 | 733,333 | 0 | 0 |
CABALETTA BIO INC | COM | 12674W109 | 3,839,364 | 464,252 | SH | | DFND | 1 | 464,252 | 0 | 0 |
CAREMAX INC | COM CL A | 14171W103 | 42,349,110 | 15,861,090 | SH | | DFND | 1 | 15,861,090 | 0 | 0 |
CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 323,770 | 672,000 | SH | | DFND | 1 | 672,000 | 0 | 0 |
CASTLE BIOSCIENCES INC | COM | 14843C105 | 6,182,907 | 272,135 | SH | | DFND | 1 | 272,135 | 0 | 0 |
CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 171,687,541 | 10,355,099 | SH | | DFND | 1 | 10,355,099 | 0 | 0 |
CENTENE CORP DEL | COM | 15135B101 | 67,950,750 | 1,075,000 | SH | | DFND | 1 | 1,075,000 | 0 | 0 |
COGENT BIOSCIENCES INC | COM | 19240Q201 | 32,006,863 | 2,966,345 | SH | | DFND | 1 | 2,966,345 | 0 | 0 |
DA32 LIFE SCNCE TEC ACQSTN C | CLASS A COM | 23312M106 | 16,192,000 | 1,600,000 | SH | | DFND | 1 | 1,600,000 | 0 | 0 |
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 80,627,957 | 5,218,638 | SH | | DFND | 1 | 5,218,638 | 0 | 0 |
DENALI THERAPEUTICS INC | COM | 24823R105 | 13,708,547 | 594,989 | SH | | DFND | 1 | 594,989 | 0 | 0 |
DOCGO INC | COM | 256086109 | 26,460,350 | 3,059,000 | SH | | DFND | 1 | 3,059,000 | 0 | 0 |
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 26,234,024 | 3,933,137 | SH | | DFND | 1 | 3,933,137 | 0 | 0 |
ENHABIT INC | COM | 29332G102 | 47,276,557 | 3,398,746 | SH | | DFND | 1 | 3,398,746 | 0 | 0 |
EUCRATES BIOMEDICAL ACQU COR | UNIT 10/23/2027 | G3141W114 | 10 | 1 | SH | | DFND | 1 | 1 | 0 | 0 |
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 13,500 | 333,333 | SH | | DFND | 1 | 333,333 | 0 | 0 |
EVOLUS INC | COM | 30052C107 | 30,193,740 | 3,569,000 | SH | | DFND | 1 | 3,569,000 | 0 | 0 |
FOGHORN THERAPEUTICS INC | COM | 344174107 | 4,820,655 | 777,525 | SH | | DFND | 1 | 777,525 | 0 | 0 |
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 10,642,710 | 2,823,000 | SH | | DFND | 1 | 2,823,000 | 0 | 0 |
GENEDX HOLDINGS CORP | COM CL A | 81663L101 | 20,875,117 | 57,192,101 | SH | | DFND | 1 | 57,192,101 | 0 | 0 |
GLAUKOS CORP | NOTE 2.750% 6/1 | 377322AB8 | 336,238,478 | 271,752,000 | PRN | | DFND | 1 | 271,752,000 | 0 | 0 |
GUARDANT HEALTH INC | NOTE 11/1 | 40131MAB5 | 59,608,534 | 89,036,000 | PRN | | DFND | 1 | 89,036,000 | 0 | 0 |
GUARDANT HEALTH INC | COM | 40131M109 | 18,259,737 | 778,999 | SH | | DFND | 1 | 778,999 | 0 | 0 |
HEALTH CATALYST INC | NOTE 2.500% 4/1 | 42225TAB3 | 27,186,090 | 30,000,000 | PRN | | DFND | 1 | 30,000,000 | 0 | 0 |
HILLEVAX INC | COM | 43157M102 | 46,840,896 | 2,833,690 | SH | | DFND | 1 | 2,833,690 | 0 | 0 |
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 23,940,012 | 1,743,628 | SH | | DFND | 1 | 1,743,628 | 0 | 0 |
INSMED INC | COM PAR $.01 | 457669307 | 11,228,209 | 658,546 | SH | | DFND | 1 | 658,546 | 0 | 0 |
INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 94,378,258 | 103,200,000 | PRN | | DFND | 1 | 103,200,000 | 0 | 0 |
INTERCEPT PHARMACEUTICALS IN | NOTE 3.250% 7/0 | 45845PAA6 | 57,036,596 | 57,791,000 | PRN | | DFND | 1 | 57,791,000 | 0 | 0 |
INTERCEPT PHARMACEUTICALS IN | NOTE 3.500% 2/1 | 45845PAC2 | 101,202,725 | 98,354,000 | PRN | | DFND | 1 | 98,354,000 | 0 | 0 |
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 39,746,100 | 734,000 | SH | | DFND | 1 | 734,000 | 0 | 0 |
INVITAE CORP | NOTE 2.000% 9/0 | 46185LAB9 | 14,146,090 | 15,711,000 | PRN | | DFND | 1 | 15,711,000 | 0 | 0 |
INVITAE CORP | COM | 46185L103 | 12,520,854 | 9,274,707 | SH | | DFND | 1 | 9,274,707 | 0 | 0 |
IONIS PHARMACEUTICALS INC | NOTE 4/0 | 462222AD2 | 116,871,183 | 127,800,000 | PRN | | DFND | 1 | 127,800,000 | 0 | 0 |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 11,191,119 | 1,831,607 | SH | | DFND | 1 | 1,831,607 | 0 | 0 |
IVERIC BIO INC | COM | 46583P102 | 36,606,383 | 1,504,578 | SH | | DFND | 1 | 1,504,578 | 0 | 0 |
KRYSTAL BIOTECH INC | COM | 501147102 | 24,974,637 | 311,949 | SH | | DFND | 1 | 311,949 | 0 | 0 |
KURA ONCOLOGY INC | COM | 50127T109 | 29,144,090 | 2,383,000 | SH | | DFND | 1 | 2,383,000 | 0 | 0 |
LARIMAR THERAPEUTICS INC | COM | 517125100 | 76,744,347 | 16,941,357 | SH | | DFND | 1 | 16,941,357 | 0 | 0 |
LIVONGO HEALTH INC | NOTE 0.875% 6/0 | 539183AA1 | 44,427,400 | 50,000,000 | PRN | | DFND | 1 | 50,000,000 | 0 | 0 |
MEDAVAIL HOLDINGS INC | COM | 58406B103 | 239,777 | 836,626 | SH | | DFND | 1 | 836,626 | 0 | 0 |
MEDTECH ACQUISITION CORP | UNIT 12/18/2025 | 58507N204 | 10 | 1 | SH | | DFND | 1 | 1 | 0 | 0 |
MEDTECH ACQUISITION CORP | *W EXP 12/22/202 | 58507N113 | 20,467 | 333,333 | SH | | DFND | 1 | 333,333 | 0 | 0 |
MERUS N V | COM | N5749R100 | 43,800,059 | 2,380,438 | SH | | DFND | 1 | 2,380,438 | 0 | 0 |
MINERALYS THERAPEUTICS INC | COM | 603170101 | 11,416,469 | 729,021 | SH | | DFND | 1 | 729,021 | 0 | 0 |
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 48,816,687 | 2,032,335 | SH | | DFND | 1 | 2,032,335 | 0 | 0 |
NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 | 63009RAD1 | 58,045,159 | 70,204,000 | PRN | | DFND | 1 | 70,204,000 | 0 | 0 |
NATERA INC | NOTE 2.250% 5/0 | 632307AB0 | 164,112,922 | 101,042,000 | PRN | | DFND | 1 | 101,042,000 | 0 | 0 |
NEOGENOMICS INC | NOTE 1.250% 5/0 | 64049MAA8 | 6,035,757 | 6,500,000 | PRN | | DFND | 1 | 6,500,000 | 0 | 0 |
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 176,599,951 | 1,744,714 | SH | | DFND | 1 | 1,744,714 | 0 | 0 |
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 170,728 | 92,787 | SH | | DFND | 1 | 92,787 | 0 | 0 |
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 33,623,687 | 2,535,723 | SH | | DFND | 1 | 2,535,723 | 0 | 0 |
NUVALENT INC | COM | 670703107 | 521,565,816 | 19,991,024 | SH | | DFND | 1 | 19,991,024 | 0 | 0 |
NUVATION BIO INC | COM CL A | 67080N101 | 9,719,068 | 5,854,860 | SH | | DFND | 1 | 5,854,860 | 0 | 0 |
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 20,000 | 166,666 | SH | | DFND | 1 | 166,666 | 0 | 0 |
NYXOAH S A | SHS | B6S7WD106 | 3,400,807 | 455,262 | SH | | DFND | 1 | 455,262 | 0 | 0 |
OAK STR HEALTH INC | NOTE 3/1 | 67181AAB3 | 15,185,063 | 15,403,000 | PRN | | DFND | 1 | 15,403,000 | 0 | 0 |
ORCHARD THERAPEUTICS PLC | SPON ADS NEW | 68570P200 | 1,697,828 | 316,169 | SH | | DFND | 1 | 316,169 | 0 | 0 |
OWENS & MINOR INC NEW | COM | 690732102 | 56,271,470 | 3,867,455 | SH | | DFND | 1 | 3,867,455 | 0 | 0 |
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 7,527,000 | 650,000 | SH | | DFND | 1 | 650,000 | 0 | 0 |
PACIRA BIOSCIENCES INC | NOTE 0.750% 8/0 | 695127AF7 | 75,026,712 | 81,600,000 | PRN | | DFND | 1 | 81,600,000 | 0 | 0 |
PRIME MEDICINE INC | COM | 74168J101 | 10,889,362 | 885,314 | SH | | DFND | 1 | 885,314 | 0 | 0 |
PTC THERAPEUTICS INC | NOTE 1.500% 9/1 | 69366JAD3 | 36,310,720 | 32,000,000 | PRN | | DFND | 1 | 32,000,000 | 0 | 0 |
PULMONX CORP | COM | 745848101 | 26,862,231 | 2,402,704 | SH | | DFND | 1 | 2,402,704 | 0 | 0 |
QUANTUM SI INC | *W EXP 06/10/202 | 74765K113 | 50,000 | 333,333 | SH | | DFND | 1 | 333,333 | 0 | 0 |
RAIN ONCOLOGY INC | COM | 75082Q105 | 1,987,415 | 227,393 | SH | | DFND | 1 | 227,393 | 0 | 0 |
REVOLUTION MEDICINES INC | COM | 76155X100 | 17,972,103 | 829,737 | SH | | DFND | 1 | 829,737 | 0 | 0 |
ROIVANT SCIENCES LTD | *W EXP 09/30/202 | G76279119 | 1,459,800 | 1,000,000 | SH | | DFND | 1 | 1,000,000 | 0 | 0 |
ROIVANT SCIENCES LTD | SHS | G76279101 | 12,915,000 | 1,750,000 | SH | | DFND | 1 | 1,750,000 | 0 | 0 |
SENIOR CONNECT ACQUISITN COR | *W EXP 12/31/202 | 81723H116 | 19,550 | 500,000 | SH | | DFND | 1 | 500,000 | 0 | 0 |
SIENTRA INC | COM | 82621J204 | 15,400 | 10,000 | SH | | DFND | 1 | 10,000 | 0 | 0 |
SILK RD MED INC | COM | 82710M100 | 67,524,293 | 1,725,640 | SH | | DFND | 1 | 1,725,640 | 0 | 0 |
SINGULAR GENOMICS SYSTEMS IN | COM | 82933R100 | 7,805,554 | 6,450,871 | SH | | DFND | 1 | 6,450,871 | 0 | 0 |
SOMALOGIC INC | *W EXP 08/31/202 | 83444K113 | 36,000 | 120,000 | SH | | DFND | 1 | 120,000 | 0 | 0 |
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 40,652,443 | 1,579,349 | SH | | DFND | 1 | 1,579,349 | 0 | 0 |
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 8,921,250 | 375,000 | SH | | DFND | 1 | 375,000 | 0 | 0 |
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 16,667 | 166,666 | SH | | DFND | 1 | 166,666 | 0 | 0 |
TABULA RASA HEALTHCARE INC | NOTE 1.750% 2/1 | 873379AA9 | 117,283,260 | 144,516,000 | PRN | | DFND | 1 | 144,516,000 | 0 | 0 |
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 14,531,322 | 1,156,032 | SH | | DFND | 1 | 1,156,032 | 0 | 0 |
TERNS PHARMACEUTICALS INC | COM | 880881107 | 24,383,545 | 2,059,421 | SH | | DFND | 1 | 2,059,421 | 0 | 0 |
THE ONCOLOGY INSTITUTE INC | COM | 68236X100 | 2,277,779 | 3,360,052 | SH | | DFND | 1 | 3,360,052 | 0 | 0 |
THE ONCOLOGY INSTITUTE INC | *W EXP 11/15/202 | 68236X118 | 81,375 | 1,250,000 | SH | | DFND | 1 | 1,250,000 | 0 | 0 |
VAXCYTE INC | COM | 92243G108 | 11,056,600 | 295,000 | SH | | DFND | 1 | 295,000 | 0 | 0 |
VENTYX BIOSCIENCES INC | COM | 92332V107 | 20,669,500 | 617,000 | SH | | DFND | 1 | 617,000 | 0 | 0 |
VERA THERAPEUTICS INC | CL A | 92337R101 | 10,088,000 | 1,300,000 | SH | | DFND | 1 | 1,300,000 | 0 | 0 |
VIATRIS INC | COM | 92556V106 | 162,924,291 | 16,935,997 | SH | | DFND | 1 | 16,935,997 | 0 | 0 |
VIGIL NEUROSCIENCE INC | COM | 92673K108 | 20,089,178 | 2,052,010 | SH | | DFND | 1 | 2,052,010 | 0 | 0 |
VIKING THERAPEUTICS INC | COM | 92686J106 | 18,731,250 | 1,125,000 | SH | | DFND | 1 | 1,125,000 | 0 | 0 |
XERIS BIOPHARMA HOLDINGS INC | NOTE 5.000% 7/1 | 98422LAA5 | 17,348,832 | 18,000,000 | PRN | | DFND | 1 | 18,000,000 | 0 | 0 |